Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Journal of Clinical and Experimental Neuropsychology|October 22, 2008
Neuroanatomical correlates of executive functioning in depressed adults with type 2 diabetesKecia Watari, Virginia Elderkin-Thompson, Olu Ajilore, et al.
Molecular Psychiatry|September 18, 2021
Transcriptomic signatures of psychomotor slowing in peripheral blood of depressed patients: evidence for immunometabolic reprogrammingMandakh Bekhbat, David R Goldsmith, Bobbi J Woolwine, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|October 21, 2016
Assessing Residents' Confidence in the Context of Pharmacotherapy CompetenceJeffrey J Rakofsky, Steven J Garlow, Ebrahim Haroon, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 9, 2004
Brain metabolites and cognitive function among older depressed and healthy individuals using 2D MR spectroscopyVirginia Elderkin-Thompson, M Albert Thomas, Nader Binesh, et al.
Schizophrenia Research|March 4, 2018
TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophreniaDavid R Goldsmith, Ebrahim Haroon, Andrew H Miller, et al.
Psychoneuroendocrinology|September 26, 2018
Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depressionMandakh Bekhbat, Karen Chu, Ngoc-Anh Le, et al.
Brain, Behavior, and Immunity|March 22, 2020
Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedoniaMandakh Bekhbat, Michael T Treadway, David R Goldsmith, et al.
Brain, Behavior, and Immunity|April 30, 2013
Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depressionDivya Mehta, Charles L Raison, Bobbi J Woolwine, et al.
Pharmacological Reviews|July 21, 2021
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological ImplicationsMichael J Lucido, Mandy Bekhbat, David R Goldsmith, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 21, 2006
Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopyOlusola Ajilore, Ebrahim Haroon, Senthil Kumaran, et al.
Pageof 7